Savant Capital LLC Has $247,000 Holdings in Maximus, Inc. $MMS

Savant Capital LLC cut its holdings in shares of Maximus, Inc. (NYSE:MMS) by 78.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,861 shares of the health services provider’s stock after selling 10,340 shares during the period. Savant Capital LLC’s holdings in Maximus were worth $247,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MMS. Boston Partners lifted its holdings in Maximus by 47.0% during the third quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after acquiring an additional 308,892 shares in the last quarter. UBS Group AG lifted its holdings in shares of Maximus by 76.8% in the fourth quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock valued at $52,686,000 after purchasing an additional 265,095 shares in the last quarter. Qube Research & Technologies Ltd lifted its holdings in shares of Maximus by 115.8% in the second quarter. Qube Research & Technologies Ltd now owns 379,342 shares of the health services provider’s stock valued at $26,630,000 after purchasing an additional 203,521 shares in the last quarter. Assenagon Asset Management S.A. bought a new stake in shares of Maximus in the fourth quarter valued at about $15,673,000. Finally, Two Sigma Investments LP bought a new stake in shares of Maximus in the third quarter valued at about $15,397,000. 97.21% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on MMS. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a report on Saturday. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold”.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Maximus Price Performance

Shares of NYSE MMS opened at $60.49 on Monday. The business’s 50 day moving average price is $63.79 and its two-hundred day moving average price is $76.60. The company has a market cap of $3.18 billion, a PE ratio of 9.06 and a beta of 0.58. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a twelve month low of $56.92 and a twelve month high of $100.00.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating the consensus estimate of $1.98 by $0.09. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts predict that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, May 15th. Maximus’s dividend payout ratio (DPR) is currently 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.